AI IS A FORCE MULTIPLIER FOR NEUROPATHOLOGY AT UC DAVIS
DEMENTIA RESEARCH IS SUPPORTED BY A GIFT FROM SUSAN AND CHARLES BERGHOFF FOUNDATION
AggieBrain: AI for Next-Generation Digital Neuropathology*
This initiative leverages Artificial Intelligence to:
- enhance neuropathology research,
- improve understanding of neurodegenerative diseases, and
- support progress toward precision medicine for dementia.
The aim is to assist medical researchers in identifying the biological underpinnings of dementia in order to improve diagnosis and treatment of this complex and devastating brain disorder.
Dementia is a Public Health Crisis
More than 7 million Americans are living with dementia today and their numbers are expected to reach 15 million by 2050. There is no cure yet for neurodegenerative diseases—the primary cause of the most common types of dementia including: Alzheimer's, Lewy body, and vascular diseases; Frontotemporal degeneration; and Mixed-etiology dementia.
AggieBrain leverages machine learning (ML) tools to help analyze massive amounts of brain autopsy data from brain tissue slides generated by whole slide imaging systems. This greatly reduces the traditionally long and laborious process of manual evaluation.
The AggieBrain Research Team
AggieBrain is led by UC Davis Professors
Dementia is an umbrella term for a progressive decline in cognitive abilities—such as memory, reasoning, and language—that is severe enough to interfere with daily life. It is not a disease per se, but a clinical syndrome caused by underlying conditions that damage brain cells.**
"It's important to understand that people can have different or multiple types of dementia, and the ability to identify and confirm informs the prognosis and recommended course of treatment," said Dugger.
Donors to AggieBrain Research
Berghoff co-founded the Susan and Charles Berghoff Foundation with his wife Sue. He was her devoted caregiver during her difficult journey with dementia. Sue proactively sought a diagnosis soon after she began experiencing cognitive changes, and became a powerful advocate and philanthropist for dementia research until her passing in
William "Bill" Ballhaus: "Convening the knowledge, skills and experience in neuropathology and AI/Machine Learning at UC Davis makes good sense. Providing an accessible framework and tools for researchers to share deep knowledge and large data sets from brain banks is critical to progress in solving the dementia challenge."
Ballhaus is the eldest son of the late
About Susan and Charles Berghoff Foundation
We envision a dementia-free world. To make this vision a reality we support dementia research, education programs, and caregiving services. We achieve this through collaboration with research centers, public health agencies and community organizations aimed at improving dementia awareness, diagnosis, treatment and care while promoting brain health and dementia prevention. Visit www.berghooff-foundation.org.
*The term "Aggie" originates from the 1920s when UC Davis was an agricultural and veterinary extension school for the University of California, Berkeley.
** Source: Cleveland Clinic.
View original content to download multimedia:https://www.prnewswire.com/news-releases/ai-is-a-force-multiplier-for-neuropathology-at-uc-davis-302795658.html
SOURCE Susan and Charles Berghoff Foundation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Foundation Provides $1 Million Grant to Expand Capital Access for Broward County Entrepreneurs
- Joint News Release Smartset Services Inc. and FinCard Financial Services Inc. Announce Binding Letter of Intent for Qualifying Transaction
- In HelloNation, Home Construction Expert Bob Pack of Howard, Ohio Explains Lake Home Building Challenges in Central Ohio
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share